EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Development and in vitro evaluation of mefenamic acid orodispersible tablets prepared by direct compression

Muhammad Adnan, Sajid Raza, Muhammad Saad, Azhar Abbas Khan, Muhammad Noman, Marzough Aziz Albalawi, Hayam A Alwabsi, Mohammed Ali Al-Duais, Mohamed Sakran, Reem A K Alharbi, Nermin I Rizk, Ibrahim Jafri und 3 weitere

Cellular and Molecular Biology · 2025

DOI: 10.14715/cmb/2025.71.5.8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular and Molecular Biology, 2025. Verfasst von Muhammad Adnan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, MY University, Islamabad, Pakistan. m_adnan14@yahoo.com. Hauptthemen laut MEDLINE: Mefenamic Acid, Tablets, Drug Compounding, Anti-Inflammatory Agents, Non-Steroidal. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mefenamic acid functions as a nonsteroidal anti-inflammatory drug (NSAID) of the fenamate class, which treats pain and inflammation by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes to decrease prostaglandin production. Mefenamic acid has strong therapeutic properties that help to treat arthritis and dysmenorrhea. The rapid dissolution of orodispersible tablets (ODTs) makes them an effective treatment option for patients with dysphagia. This study developed and evaluated mefenamic acid ODTs through direct compression while adding super-disintegrants, including croscarmellose sodium, crospovidone, and sodium starch glycolate, to improve drug release and disintegration speed. Pre-formulation analysis through FTIR spectroscopy showed that the drug and excipients maintained compatibility without detectable interactions. Product quality assessment included tests for hardness and weight variation, friability and disintegration time, dissolution studies, and stability testing. The performance of the formulation was evaluated through supplementary tests that measured the moisture uptake, wetting time, and water absorption ratio. The zero-order model provided the most accurate explanation of drug release kinetics among the model-dependent approaches, which included the zero-order, first-order, Higuchi, and Hixson-Crowell models. The combination of 7% croscarmellose sodium in formulation F1 produced the best results by enabling quick dissolution while maintaining the optimal disintegration time and improving drug absorption and patient compliance. Stability tests showed that the formulation structure remained consistent during the entire testing period, thus proving its durability. The direct compression method was effective for manufacturing stable mefenamic acid ODTs according to this research. This research demonstrates how super-disintegrants boost formulation performance, establishing ODTs as a promising drug delivery system for better therapeutic results and patient medication compliance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mefenamic AcidTabletsDrug CompoundingAnti-Inflammatory Agents, Non-SteroidalDrug LiberationSolubilityExcipientsHardnessChemistry, PharmaceuticalSpectroscopy, Fourier Transform InfraredPovidoneCarboxymethylcellulose SodiumHumansStarch

Substanzen

Mefenamic AcidTabletsAnti-Inflammatory Agents, Non-SteroidalExcipientsPovidonesodium starch glycolateCarboxymethylcellulose SodiumStarch

Autor:innen und Institutionen

  • Faculty of Pharmacy, MY University, Islamabad, Pakistan. m_adnan14@yahoo.com.
  • Faculty of Pharmacy, IBADAT International University Islamabad, Pakistan. sajid.raza@iiui.edu.pk.
  • Faculty of Pharmacy, IBADAT International University Islamabad, Pakistan. drmsaad1996@gmail.com.
  • Department of Biochemistry, Hazara University, Mansehra, KP, Pakistan. azharabbaskhan84@gmail.com.
  • Faculty of Pharmacy, IBADAT International University Islamabad, Pakistan. muhammad.nomankhan11@gmail.com.
  • Department of Biochemistry, Faculty of Science, University of Tabuk, Tabuk 73000, Kingdom of Saudi. maalbalawi@ut.edu.sa.

Zitieren

APA

Adnan, M., Raza, S., Saad, M., Khan, A. A., Noman, M., Aziz Albalawi, M., Alwabsi, H. A., Ali Al-Duais, M., Sakran, M., Alharbi, R. A. K., Rizk, N. I., Jafri, I., Zayed, M. M., Pandey, S., & El Sabagh, A. (2025). Development and in vitro evaluation of mefenamic acid orodispersible tablets prepared by direct compression. Cellular and Molecular Biology. https://doi.org/10.14715/cmb/2025.71.5.8

Vancouver

Adnan M, Raza S, Saad M, Khan AA, Noman M, Aziz Albalawi M, et al. Development and in vitro evaluation of mefenamic acid orodispersible tablets prepared by direct compression. Cellular and Molecular Biology. 2025. doi:10.14715/cmb/2025.71.5.8

BibTeX
@article{Adnan2025,
  author = {Adnan, Muhammad and Raza, Sajid and Saad, Muhammad and Khan, Azhar Abbas and Noman, Muhammad and Aziz Albalawi, Marzough and Alwabsi, Hayam A and Ali Al-Duais, Mohammed and Sakran, Mohamed and Alharbi, Reem A K and Rizk, Nermin I and Jafri, Ibrahim and Zayed, Mohamed M and Pandey, Saurabh and El Sabagh, Ayman},
  title = {Development and in vitro evaluation of mefenamic acid orodispersible tablets prepared by direct compression},
  journal = {Cellular and Molecular Biology},
  year = {2025},
  doi = {10.14715/cmb/2025.71.5.8}
}
Kostenlos starten →